ArticleDiseases (Basel, Switzerland)2026

Bevacizumab and Tocotrienol in Recurrent Platinum-Resistant Ovarian Cancer, and the Role of HOXA9 as a Prognostic Biomarker.

Elisabeth Emanuel Graae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.